US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
To-be Listed
Name
/
Code
Industry Offer Price Lot Size Entry Fee Closing Date
Grey Market Date
Listing Date
S.F. Holding
06936.HK
Air Freight & Logistics 32.3-36.3 200 N/A 2024/11/22 2024/11/26 2024/11/27
Jiuyuan Gene
02566.HK
Biotechnology - Medical Devices 11.48-12.56 200 N/A 2024/11/25 2024/11/27 2024/11/28
Mokingran
02585.HK
Watch & Jewellery 12-14.4 200 N/A 2024/11/26 2024/11/28 2024/11/29
Summary
Our Company

We developed China’s first city-specific cloud hospital platform, according to Frost & Sullivan, and nurtured a cloud hospital network that connects local governments, medical institutions, patients and insurers to enable equitable access to medical resources and more effective and efficient delivery of healthcare. Through the cloud hospital network, we facilitate the delivery of Internet medical services, including online hospital services, remote medical services, smart family doctor services and Internet home care services. We also provide health management services and offer smart healthcare products. According to Frost & Sullivan, as of March 31, 2023, we are the largest cloud hospital network in China in terms of the number of cities covered.

Digital healthcare is the integration of information technology with medical resources and practices to create new healthcare service platforms and infrastructure, and to enable stakeholders to deliver more precise and customized care with improved quality and equitable access. Through digital healthcare, we help relevant stakeholders realize healthcare transformation to achieve digital connection between online and offline settings, inside and outside of medical institutions and among medical institutions, and solve diverse and systemic problems facing the healthcare system. We believe that the core value of cloud-based healthcare should reside with empowering all participants in the healthcare system, to align with all relevant stakeholders’ interests without disrupting the system as a whole.

As of December 31, 2020 and March 31, 2023, our network grew from 24 to 29 city-specific cloud hospital platforms in China. As of the same dates, 1,796 to 2,500 hospitals were connected to our cloud hospital network, respectively. We believe our cloud hospital platforms can generate strong network effects as more hospitals and other participants join our platforms over time to expand the depth and breadth of medical resources available and the reach to an ever-larger group of healthcare consumers, resulting in a virtuous cycle in sustaining our growth.

Our Solutions

We have created a portfolio of solutions designed to empower the participants in the healthcare system to improve overall efficiency and effectiveness.

Our solutions are designed to generate synergistic effects among themselves. Our cloud hospital platform services, serving as the entry point of our solutions, connect the healthcare participants to our cloud infrastructure, thereby allowing them access to our SaaS tools and medical service modules. Our Internet medical services empower medical institutions to offer convenient and one-stop online and offline integrated medical services inside and outside of medical institutions to patients throughout the full healthcare cycle. We also provide offline health management services through our own medical institutions to individuals and institutional clients, so as to enable them or their employees to manage health alongside our Internet medical services. Furthermore, smart healthcare products have enriched the healthcare scenarios so that our solutions can benefit the end patients and healthcare consumers, and created room for us to further enrich our service offerings. We expect our solutions to further attract healthcare participants to our platforms and increase quality medical resources available through our platforms, thereby resulting in a virtuous cycle for our sustainable growth.

Our cloud hospital platforms are an important feature of our solutions, particularly the cloud hospital platform services and Internet medical services. Such city-specific cloud hospital platforms are typically established through the offering of our cloud hospital platform services, and are utilized to facilitate the offering of the Internet medical services, while the maintenance and upgrade of such platforms further drive the growth of our cloud hospital platform services. These platforms can aggregate and organize the health data generated through our healthcare products, along with the EMRs and other health data from our customers of the cloud hospital platform services as well as EHRs from our provision of health management services, to produce more accurate personal health profiles that allow the delivery of more precise and personalized care.



Source: Neusoft Xikang (09686) Prospectus (IPO Date : 2023/09/18)
Listing Market MAIN
Industry Health Care Services
Background Others
Major Business Area N/A
Corporate Information
Substantial Shareholders Neusoft Corporation (23.66%)
Dalian Neusoft Holdings Co., Ltd. (20.41%)
[02328] PICC Property and Casualty Company Limited (12.11%)
Hony Capital Fund V GP, L.P. (10.30%)
Zhang Qiping (7.69%)
Synergetic Innovation Fund Management Co., Ltd (5.05%)
Directors LIU Jiren (Chairman and Non-Executive Director)
ZONG Wenhong (Chief Executive Officer and Executive Director)
CHEN Lianyong (Non-Executive Director)
PU Chengchuan (Non-Executive Director)
WANG Nan (Non-Executive Director)
Xu Hongli (Non-Executive Director)
CHEN Yan (Independent Non-Executive Director)
YIN Guisheng (Independent Non-Executive Director)
QI Guoxian (Independent Non-Executive Director)
Company Secretary WONG Wai Chiu
Zhao Shu
Principal Bankers China Merchants Bank
Industrial Bank Co., Ltd
Solicitors Clifford Chance
Tian Yuan Law Firm
Maples and Calder (Hong Kong) LLP
Auditors Ernst & Young
Registered Office 40th Floor, Dah Sing Financial Centre, 248 Queen’s Road East, Wan Chai, Hong Kong
Share Registrars Computershare Hong Kong Investor Services Ltd. [Tel: (852) 2862-8628]
Share Registrars Tel No (852) 2862-8628
Internet Address http://www.xikang.com
Email Address xikang-service@neusoft.com
Tel No (86 400) 8590-590
Fax No
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 6 January 2023.